Critical Path Paved With Fewer Patients
This article was originally published in The Pink Sheet Daily
FDA Deputy Commissioner Gottlieb says that the agency's innovation initiative will produce smaller trial requirements stemming from a better understanding of drug mechanics.
You may also be interested in...
The agency will issue a total of five guidance documents regarding adaptive clinical trials, the first of which will examine using multiple endpoints in the same trial.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13